What Is Selank?
Selank is a synthetic heptapeptide developed alongside Semax at the Institute of Molecular Genetics of the Russian Academy of Sciences. It was derived from tuftsin, a naturally occurring immunomodulatory tetrapeptide (Thr-Lys-Pro-Arg) produced by the spleen, with the addition of a stabilizing Pro-Gly-Pro sequence that dramatically extends its half-life in the bloodstream and at the blood-brain barrier.
Selank was developed with a specific therapeutic goal: create an anxiolytic compound that does not carry the sedation, cognitive impairment, dependency, or withdrawal profile of benzodiazepines. After more than two decades of development and clinical testing in Russia, it was registered as a pharmaceutical drug for anxiety and asthenic conditions. In the research peptide community, it has developed a reputation as one of the cleanest anxiolytics available — one that paradoxically enhances cognitive performance rather than blunting it.
What sets Selank apart from virtually every other anxiolytic is the simultaneity of its effects: it reduces anxiety while improving working memory, verbal fluency, and attention. For individuals whose cognitive performance is impaired by anxiety — which describes a significant portion of high-performing individuals — Selank offers a compelling solution by addressing the root interference rather than applying a pharmacological brake to the entire nervous system.
Selank is classified as a research compound in most Western jurisdictions and is not FDA-approved for clinical use.
Mechanism of Action
Selank's mechanism of action is elegantly multi-targeted, which accounts for its unique ability to produce anxiolysis and cognitive enhancement simultaneously rather than as a tradeoff.
GABAergic Modulation: Selank modulates the GABA-A receptor complex — the same system targeted by benzodiazepines — but does so in a subtler, more selective manner. Rather than acting as a direct positive allosteric modulator at the benzodiazepine binding site (which produces broad CNS depression), Selank appears to influence GABA transmission through indirect mechanisms that normalize excessive anxiety signaling without producing global inhibition. This explains the absence of sedation, motor impairment, and cognitive dulling characteristic of classical anxiolytics.
Enkephalin Metabolism: One of Selank's most distinctive mechanisms is its inhibition of enzymes responsible for degrading enkephalins — endogenous opioid peptides involved in mood regulation and pain modulation. By slowing enkephalin breakdown, Selank effectively extends and amplifies the brain's own mood-stabilizing chemistry. This is a fundamentally different approach from exogenous opioids and does not produce tolerance or dependence in the same manner.
BDNF Upregulation: Like its close relative Semax, Selank has been shown to upregulate Brain-Derived Neurotrophic Factor in limbic regions. BDNF elevation in the hippocampus and prefrontal cortex not only supports memory and learning but has well-established anxiolytic effects in its own right — reduced BDNF is associated with anxiety disorders and depression.
Immune and Cytokine Modulation: As a tuftsin analogue, Selank retains immunomodulatory properties. It regulates the balance of IL-6 and T-helper cell activity, and has been studied for its role in normalizing immune responses during stress states. Chronic anxiety and immune dysregulation are deeply linked, and Selank's ability to address both systems simultaneously represents a genuinely integrated approach to stress physiology.
Serotonergic Influence: Selank appears to modulate serotonin transporter expression in brain regions associated with emotional regulation, contributing to its anxiolytic and mood-stabilizing effects without the time-lag or discontinuation syndrome of SSRIs.
Key Benefits
Anxiety Without Sedation
The defining characteristic of Selank — genuine anxiolytic effect without any of the cognitive dulling, drowsiness, or motor impairment of benzodiazepines or antihistamine-based anxiolytics.
Working Memory Improvement
Multiple studies demonstrate improvement in verbal working memory, attention span, and information processing speed — an effect that compounds over a dosing cycle.
BDNF Elevation
Promotes BDNF expression in limbic and cortical regions, supporting neuroplasticity and providing a biological mechanism for the sustained cognitive improvements users report after cycle completion.
Immune Modulation
Inherited from its tuftsin parent structure, Selank demonstrates immunomodulatory effects including normalization of IL-6 levels and T-helper cell balance — particularly relevant during periods of high stress.
No Dependency or Withdrawal
Unlike benzodiazepines, Selank does not produce physical dependence, receptor downregulation tolerance, or withdrawal syndrome. Cessation is clean and abrupt discontinuation presents no significant risk.
Performance Under Stress
Users report significantly better cognitive performance in high-pressure situations — presentations, competitive events, social demands — without the performance-impairing edge of anxiety.
Dosing & Protocol
| Use Case | Daily Dose | Timing | Notes |
|---|---|---|---|
| Anxiolytic (daytime) | 250–300 mcg | Morning, with or without food | Split AM/midday if needed |
| Cognitive Enhancement | 300–500 mcg | Morning, fasted preferred | 30–45 min before demanding work |
| Pre-Sleep / Anxiolytic | 250 mcg | 30 min before bed | See Selank sleep page for details |
Cycle Structure: Standard cycling is 14 days on, 7 days off. Some protocols extend to 21 days with a 10-day break. The off-cycle period is not truly "inactive" — BDNF and enkephalin-mediated effects persist for days to weeks after cessation.
Onset and Duration: Acute anxiolytic and focus-enhancing effects typically onset within 20–30 minutes of intranasal administration. Duration is approximately 4–6 hours per dose. Unlike fast-acting benzodiazepines, the effect builds smoothly rather than hitting abruptly.
Storage: Refrigerate between 2–8°C. Protect from light. Most formulations remain stable for 6+ months when stored correctly. Do not freeze.
Side Effects & Safety
Selank has an exceptionally clean safety profile — arguably the cleanest of any anxiolytic compound in widespread research use. This is by design, having been specifically engineered to avoid the adverse effect profile of benzodiazepines.
No Dependency Profile: This is clinically significant. Selank does not produce the receptor downregulation, tolerance, or physical dependence associated with benzodiazepines. Animal studies demonstrate no withdrawal syndrome upon abrupt cessation, even after prolonged use.
No Cognitive Impairment: Selank does not impair reaction time, motor coordination, or cognitive processing at recommended doses — in fact, the data consistently shows cognitive improvement. This stands in stark contrast to classical anxiolytics.
Interactions: Use caution combining Selank with other GABAergic compounds (alcohol, benzodiazepines, phenibut) as additive sedation is theoretically possible at higher doses. The combination is not inherently dangerous but warrants conservative dosing.
Contraindications: No absolute contraindications established in the research literature beyond standard pregnancy/breastfeeding caution. Individuals on psychiatric medications should consult a physician before use.
Stacking Guide
Selank's complementary mechanism profile makes it an excellent stack partner for several compounds, particularly Semax.
The Classic Cognitive Stack: Semax (300 mcg intranasal, morning) + Selank (250 mcg intranasal, afternoon or pre-sleep). Semax provides the anabolic BDNF drive and cortical activation in the morning; Selank's anxiolytic and enkephalin effects smooth the day and prepare the nervous system for quality sleep. This combination is widely regarded as one of the most balanced and well-tolerated in the research peptide community.
Pre-Sleep Application: 250 mcg of Selank 30 minutes before bed can significantly reduce the cognitive rumination and anxiety that interfere with sleep onset. Unlike sleep-promoting compounds, it does not cause grogginess — if you're not tired, it simply reduces the anxiety without forcing sleep. See the Selank Sleep Application page for the full protocol.
Get Personalized Stack Recommendations
Join SDBioHack free to access our stack builder, protocol database, and member community.
Frequently Asked Questions
At recommended doses (250–500 mcg), Selank does not produce sedation or cognitive impairment. This is one of its defining characteristics. Most users describe the experience as a reduction in background mental noise and anxiety — thoughts become clearer, not slower. Some very sensitive individuals report mild relaxation at higher doses (above 600 mcg), but this is distinct from the cognitive impairment produced by benzodiazepines. If you're concerned, start at 250 mcg and assess your personal response before increasing.
The comparison is significant but the compounds are fundamentally different. Benzodiazepines are potent positive allosteric modulators of GABA-A receptors — they work fast, powerfully, and non-selectively, suppressing activity across the CNS. They are highly effective for acute anxiety but carry serious risks: tolerance, dependence, cognitive impairment, and a dangerous withdrawal syndrome. Selank works through a more nuanced mechanism — modulating GABA indirectly, preserving enkephalins, and upregulating BDNF — to produce anxiolysis without CNS suppression. It is weaker and slower-acting than benzodiazepines, but for chronic anxiety management and performance contexts, the risk-benefit profile is dramatically different. Selank should not be used as an acute panic treatment or as a benzodiazepine substitute in withdrawal management.
The standard recommendation is to cycle Selank (14 days on, 7 days off) rather than using it continuously. The reasoning is practical rather than safety-based: Selank's neurotrophic effects appear to persist through the off-cycle, meaning breaks do not negate gains. Cycling also helps you maintain sensitivity to the compound's effects and gives you baseline periods to assess your underlying anxiety levels without pharmacological assistance. Some individuals use Selank continuously for specific clinical indications under physician supervision. For a research context, the cycling protocol is the evidence-informed default.
Key References
- Semenova TP, et al. "Selank modulates the expression of genes related to GABA metabolism in rats." Doklady Biochemistry and Biophysics, 2010.
- Filatova EV, et al. "Selank and short peptides of the tuftsin family in the regulation of adaptive behavior in stress." Neuroscience and Behavioral Physiology, 2007.
- Uchakina ON, et al. "Immunomodulatory effects of Selank in patients with anxiety-asthenic disorders." Zhurnal Nevrologii i Psikhiatrii, 2008.
- Kozlovskaya MM, et al. "Selank effects on the expression of genes encoding BDNF and its receptor TrkB in rat brain structures." Bulletin of Experimental Biology and Medicine, 2014.